학술논문
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia
Document Type
Article
Author
Source
In European Journal of Pain 2011 15(5):509-514
Subject
Language
ISSN
1090-3801